AnaptysBio, Inc. ANAB Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s operating cash flow?
- AnaptysBio, Inc. (ANAB) reported operating cash flow of -$25.92M in Q1 2026.
- How has AnaptysBio, Inc.'s operating cash flow changed year-over-year?
- AnaptysBio, Inc.'s operating cash flow decreased by 142.2% year-over-year, from -$10.7M to -$25.92M.
- What is the long-term trend for AnaptysBio, Inc.'s operating cash flow?
- Over 3 years (2022 to 2025), AnaptysBio, Inc.'s operating cash flow has grown at a -35.6% compound annual growth rate (CAGR), from -$73.59M to $19.7M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.